Literature DB >> 8621609

Mannose enters mammalian cells using a specific transporter that is insensitive to glucose.

K Panneerselvam1, H H Freeze.   

Abstract

The concentration of D-mannose in serum is 20-50 micron, but its physiological significance for glycoprotein synthesis is unknown. Here, we show that the uptake of D-mannose by different mammalian cell lines involves a mannose-specific transporter(s) with a K(uptake) of about 30-70 micron and a V(max) which is probably sufficient to account for the bulk of mannose needed for glycoprotein synthesis. Mannose uptake appears to be through a facilitated transport process since it is not inhibited by cyanide. Phloretin completely inhibits mannose uptake, but phloridzin inhibits only 25-30%. Both of these inhibitors can block 2-deoxyglucose uptake in fibroblasts which occurs through the typical glucose transporters. None of 9 other sugars tested inhibited mannose transport. Most importantly, 5 mM D-glucose only inhibits mannose uptake by 50% showing that it is not an efficient competitor. These results suggest that this transporter(s) may use serum mannose for glycoprotein synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621609     DOI: 10.1074/jbc.271.16.9417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Mannose efflux from the cells: a potential source of mannose in blood.

Authors:  Vandana Sharma; Hudson H Freeze
Journal:  J Biol Chem       Date:  2011-01-27       Impact factor: 5.157

2.  Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes.

Authors:  Barton C Staat; Henry L Galan; Jeri E F Harwood; Gene Lee; Anna Maria Marconi; Cinzia L Paolini; Alex Cheung; Frederick C Battaglia
Journal:  J Clin Endocrinol Metab       Date:  2012-04-27       Impact factor: 5.958

3.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.

Authors:  Günter Oberdörster; Andrew Maynard; Ken Donaldson; Vincent Castranova; Julie Fitzpatrick; Kevin Ausman; Janet Carter; Barbara Karn; Wolfgang Kreyling; David Lai; Stephen Olin; Nancy Monteiro-Riviere; David Warheit; Hong Yang
Journal:  Part Fibre Toxicol       Date:  2005-10-06       Impact factor: 9.400

4.  Human metabolic individuality in biomedical and pharmaceutical research.

Authors:  So-Youn Shin; Ann-Kristin Petersen; Nicole Soranzo; Christian Gieger; Karsten Suhre; Robert P Mohney; David Meredith; Brigitte Wägele; Elisabeth Altmaier; Panos Deloukas; Jeanette Erdmann; Elin Grundberg; Christopher J Hammond; Martin Hrabé de Angelis; Gabi Kastenmüller; Anna Köttgen; Florian Kronenberg; Massimo Mangino; Christa Meisinger; Thomas Meitinger; Hans-Werner Mewes; Michael V Milburn; Cornelia Prehn; Johannes Raffler; Janina S Ried; Werner Römisch-Margl; Nilesh J Samani; Kerrin S Small; H-Erich Wichmann; Guangju Zhai; Thomas Illig; Tim D Spector; Jerzy Adamski
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

5.  Evolutionary conservation of human ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis.

Authors:  Kunio Kawanishi; Sudeshna Saha; Sandra Diaz; Michael Vaill; Aniruddha Sasmal; Shoib S Siddiqui; Biswa Choudhury; Kumar Sharma; Xi Chen; Ian C Schoenhofen; Chihiro Sato; Ken Kitajima; Hudson H Freeze; Anja Münster-Kühnel; Ajit Varki
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

6.  Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs.

Authors:  Shinji Go; Chihiro Sato; Kimio Furuhata; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

Review 7.  Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature.

Authors:  D Marques-da-Silva; V Dos Reis Ferreira; M Monticelli; P Janeiro; P A Videira; P Witters; J Jaeken; D Cassiman
Journal:  J Inherit Metab Dis       Date:  2017-01-20       Impact factor: 4.982

8.  Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose.

Authors:  C Körner; L Lehle; K von Figura
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

9.  Clinical significance of plasma mannose concentrations in healthy and diabetic dogs.

Authors:  A Mori; T Sato; P Lee; M Furuuchi; H Tazaki; K Katayama; H Mizutani; T Sako; T Arai
Journal:  Vet Res Commun       Date:  2008-12-13       Impact factor: 2.459

Review 10.  Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.

Authors:  Anna Čechová; Ruqaiah Altassan; Delphine Borgel; Arnaud Bruneel; Joana Correia; Muriel Girard; Annie Harroche; Beata Kiec-Wilk; Klaus Mohnike; Tiffany Pascreau; Łukasz Pawliński; Silvia Radenkovic; Sandrine Vuillaumier-Barrot; Luis Aldamiz-Echevarria; Maria Luz Couce; Esmeralda G Martins; Dulce Quelhas; Eva Morava; Pascale de Lonlay; Peter Witters; Tomáš Honzík
Journal:  J Inherit Metab Dis       Date:  2020-04-21       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.